Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol

The potential of proniosomes as a transdermal drug delivery system for Atenolol was investigated by encapsulating the drug in various formulations of proniosomal gel composed of various ratios of sorbitan fatty acid esters, cholesterol, lecithin prepared by Coacervation-phase separation method. The...

Full description

Bibliographic Details
Main Authors: S. Ramkanth, C. Madhusudhana Chetty, Y. Sudhakar, V.S. Thiruvengadarajan, P. Anitha, C. Gopinath
Format: Article
Language:English
Published: SpringerOpen 2018-06-01
Series:Future Journal of Pharmaceutical Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S2314724516301029
_version_ 1828409463746330624
author S. Ramkanth
C. Madhusudhana Chetty
Y. Sudhakar
V.S. Thiruvengadarajan
P. Anitha
C. Gopinath
author_facet S. Ramkanth
C. Madhusudhana Chetty
Y. Sudhakar
V.S. Thiruvengadarajan
P. Anitha
C. Gopinath
author_sort S. Ramkanth
collection DOAJ
description The potential of proniosomes as a transdermal drug delivery system for Atenolol was investigated by encapsulating the drug in various formulations of proniosomal gel composed of various ratios of sorbitan fatty acid esters, cholesterol, lecithin prepared by Coacervation-phase separation method. The objectives of the present study were to define effects on the antihypertension activity and pharmacokinetics of a novel transdermal Proniosomal gel incorporating Atenolol. The formulated systems were characterized in vitro for size, drug entrapment, In vitro and in vivo drug permeation profiles and vesicular stability at different storage conditions. The optimized Atenolol proniosomes (AT8) showed nanometric vesicle size, high entrapment efficiency and marked enhancement in transdermal permeation. The prepared Proniosomal gel showed the relative bioavailability of 365.38 fold increased for AT8 than oral. The maximal concentrations (Cmax), of drug were significantly reduced while the areas under the plasma concentration–time curve (AUC), and mean residence times (MRT), t1/2 were evidently increased and extended, respectively. The results suggest that proniosomes can act as promising carrier which offers an alternative approach for transdermal delivery of Atenolol. Keywords: Proniosomes, Atenolol, Niosomes, Pharmacokinetic study, Transdermal delivery
first_indexed 2024-12-10T11:56:14Z
format Article
id doaj.art-1f780179d2cb4dd98c6a1d2644b937e6
institution Directory Open Access Journal
issn 2314-7245
language English
last_indexed 2024-12-10T11:56:14Z
publishDate 2018-06-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj.art-1f780179d2cb4dd98c6a1d2644b937e62022-12-22T01:49:47ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72452018-06-01418087Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of AtenololS. Ramkanth0C. Madhusudhana Chetty1Y. Sudhakar2V.S. Thiruvengadarajan3P. Anitha4C. Gopinath5Annamacharya College of Pharmacy, Rajampet, 516126, Andhra Pradesh, India; Corresponding author. Department of Pharmaceutics, Annamacharya College of Pharmacy, Rajampet, 516126, Andhra Pradesh, India. Tel.: +91 9618312122.Santhiram College of Pharmacy, Nandyal, Andhra Pradesh, IndiaS V Government Polytechnic, Tirupathi, Andhra Pradesh, IndiaAnnamacharya College of Pharmacy, Rajampet, 516126, Andhra Pradesh, IndiaAnnamacharya College of Pharmacy, Rajampet, 516126, Andhra Pradesh, IndiaAnnamacharya College of Pharmacy, Rajampet, 516126, Andhra Pradesh, IndiaThe potential of proniosomes as a transdermal drug delivery system for Atenolol was investigated by encapsulating the drug in various formulations of proniosomal gel composed of various ratios of sorbitan fatty acid esters, cholesterol, lecithin prepared by Coacervation-phase separation method. The objectives of the present study were to define effects on the antihypertension activity and pharmacokinetics of a novel transdermal Proniosomal gel incorporating Atenolol. The formulated systems were characterized in vitro for size, drug entrapment, In vitro and in vivo drug permeation profiles and vesicular stability at different storage conditions. The optimized Atenolol proniosomes (AT8) showed nanometric vesicle size, high entrapment efficiency and marked enhancement in transdermal permeation. The prepared Proniosomal gel showed the relative bioavailability of 365.38 fold increased for AT8 than oral. The maximal concentrations (Cmax), of drug were significantly reduced while the areas under the plasma concentration–time curve (AUC), and mean residence times (MRT), t1/2 were evidently increased and extended, respectively. The results suggest that proniosomes can act as promising carrier which offers an alternative approach for transdermal delivery of Atenolol. Keywords: Proniosomes, Atenolol, Niosomes, Pharmacokinetic study, Transdermal deliveryhttp://www.sciencedirect.com/science/article/pii/S2314724516301029
spellingShingle S. Ramkanth
C. Madhusudhana Chetty
Y. Sudhakar
V.S. Thiruvengadarajan
P. Anitha
C. Gopinath
Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol
Future Journal of Pharmaceutical Sciences
title Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol
title_full Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol
title_fullStr Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol
title_full_unstemmed Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol
title_short Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol
title_sort development characterization invivo evaluation of proniosomal based transdermal delivery system of atenolol
url http://www.sciencedirect.com/science/article/pii/S2314724516301029
work_keys_str_mv AT sramkanth developmentcharacterizationinvivoevaluationofproniosomalbasedtransdermaldeliverysystemofatenolol
AT cmadhusudhanachetty developmentcharacterizationinvivoevaluationofproniosomalbasedtransdermaldeliverysystemofatenolol
AT ysudhakar developmentcharacterizationinvivoevaluationofproniosomalbasedtransdermaldeliverysystemofatenolol
AT vsthiruvengadarajan developmentcharacterizationinvivoevaluationofproniosomalbasedtransdermaldeliverysystemofatenolol
AT panitha developmentcharacterizationinvivoevaluationofproniosomalbasedtransdermaldeliverysystemofatenolol
AT cgopinath developmentcharacterizationinvivoevaluationofproniosomalbasedtransdermaldeliverysystemofatenolol